Basel, Switzerland

Thomas Bohnacker

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 7.2

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2017-2021

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Thomas Bohnacker: Innovator in Pharmaceutical Compounds

Introduction

Thomas Bohnacker is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceutical compounds, particularly in the development of inhibitors for various kinases. With a total of three patents to his name, Bohnacker's work is recognized for its potential therapeutic applications.

Latest Patents

Bohnacker's latest patents include innovative compounds known as difluoromethyl-aminopyridines and difluoromethyl-aminopyrimidines. These inventions relate to novel phosphoinositide 3-kinase (PI3K), mammalian target of rapamycin (mTOR), and PI3K-related kinase (PIKKs) inhibitor compounds. The compounds are characterized by a specific formula, wherein certain variables can be nitrogen or carbon, with the stipulation that at least two of them must be nitrogen. These compounds are designed to be useful, either alone or in combination with other therapeutic agents, for treating disorders mediated by lipid kinases.

Career Highlights

Throughout his career, Thomas Bohnacker has worked with prominent organizations such as Piqur Therapeutics AG and Universität Basel. His experience in these institutions has allowed him to advance his research and contribute to the development of innovative therapeutic solutions.

Collaborations

Bohnacker has collaborated with notable colleagues, including Vladimir Cmiljanovic and Paul Hebeisen. These partnerships have played a crucial role in enhancing his research and expanding the impact of his inventions.

Conclusion

Thomas Bohnacker is a distinguished inventor whose work in pharmaceutical compounds has the potential to significantly impact the treatment of various disorders. His innovative patents and collaborations highlight his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…